| NSCLC | Non-small cell lung cancer |
| LAC | Lung adenocarcinoma |
| SCC | Squamous cell carcinoma |
| LCC | Large cell carcinoma |
| LCNEC | Large cell neuroendocrine carcinoma |
| SCLC | Small cell carcinoma |
| EBUS | Endobronchial ultrasound-guided biopsy |
| IHC | Immunohistochemistry |
| LN | Lymph node |
| TPS | Tumor proportion/positivity score |
| AI | Artificial intelligence |
| IASLC | International Association for the Study of Lung Cancer |
| pCR | Pathological complete response |
| MPR | Major pathological response |
| RG | Regression grade |
| RVT | Residual vital tumor |
| ESMO | European Society of Medical Oncology |
| ESCAT | ESMO Scale for clinical actionability of molecular targets |
| NGS | Next-Generation Sequencing |
| FISH | Fluorescene in situ hybridization |
| EMMP | European Masters in Molecular Pathology |